These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 14371655)

  • 21. [Laboratory changes and complications during long-term therapy of Wilson's disease using D-penicillamine].
    Hauftová D; Slavícek J; Hartl J; Seidlová V; Komenda S
    Vnitr Lek; 1970 Apr; 16(4):344-53. PubMed ID: 5443326
    [No Abstract]   [Full Text] [Related]  

  • 22. Reaction of brain copper proteins with sodium diethyldithiocarbamate in normal and in hepatolenticular degeneration.
    PORTER H; AINSWORTH S
    Proc Soc Exp Biol Med; 1958 Jun; 98(2):277-80. PubMed ID: 13554617
    [No Abstract]   [Full Text] [Related]  

  • 23. The familial nature of the amino-aciduria of Wilson's disease (hepatolenticular degeneration).
    UZMAN LL; HOOD B
    Am J Med Sci; 1952 Apr; 223(4):392-400. PubMed ID: 14914748
    [No Abstract]   [Full Text] [Related]  

  • 24. [Hepatolenticular degeneration: a new metabolic disease].
    BOUDIN G; PEPIN B
    Presse Med (1893); 1954 Feb; 62(12):243-5. PubMed ID: 13145588
    [No Abstract]   [Full Text] [Related]  

  • 25. Studies on copper metabolism. XIV. Radioactive copper studies in normal subjects and in patients with hepatolenticular degeneration.
    BUSH JA; MAHONEY JP; MARKOWITZ H; GUBLER CJ; CARTWRIGHT GE; WINTROBE MM
    J Clin Invest; 1955 Dec; 34(12):1766-78. PubMed ID: 13271562
    [No Abstract]   [Full Text] [Related]  

  • 26. Seminars on Lesch-Nyhan syndrome. Discussion of unanswered questions.
    Fed Proc; 1968; 27(4):107-12. PubMed ID: 4232133
    [No Abstract]   [Full Text] [Related]  

  • 27. Renal urate excretion in patients with Wilson's disease.
    Wilson DM; Goldstein NP
    Kidney Int; 1973 Nov; 4(5):331-6. PubMed ID: 4762580
    [No Abstract]   [Full Text] [Related]  

  • 28. Pyruvate metabolism in Wilson's disease.
    WALSHE JM
    Clin Sci; 1961 Apr; 20():197-203. PubMed ID: 13782931
    [No Abstract]   [Full Text] [Related]  

  • 29. The effect of drugs upon the copper metabolism in hepatolenticular degeneration and in normal subjects.
    ZIMDAHL WT; HYMAN I; STAFFORD WF
    J Lab Clin Med; 1954 May; 43(5):774-84. PubMed ID: 13163577
    [No Abstract]   [Full Text] [Related]  

  • 30. [Disorders of copper and amino acid metabolism in hepato-cerebral degeneration and their treatment with BAL].
    STEGER J; STEGER R
    Dtsch Z Nervenheilkd; 1954; 172(4):321-51. PubMed ID: 14365436
    [No Abstract]   [Full Text] [Related]  

  • 31. [Copper metabolism in hepato-lenticular degeneration thiol therapy].
    KONOVALOV NV; MUTTEL'SHTEDT AA; BAUMAN LK; GOTOVTSEVA EV
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1957; 57(1):39-48. PubMed ID: 13434449
    [No Abstract]   [Full Text] [Related]  

  • 32. Comparative metabolism of copper and zinc in patients with Wilson's disease (hepatolenticular degeneration).
    McCall JT; Goldstein NP; Randall RV; Gross JB
    Am J Med Sci; 1967 Jul; 254(1):13-23. PubMed ID: 6027683
    [No Abstract]   [Full Text] [Related]  

  • 33. [Amino acid studies in Wilson disease].
    KISFALUDY S; BRAUN P
    Magy Belorv Arch (1955); 1957; 10(5-6):144-8. PubMed ID: 13526501
    [No Abstract]   [Full Text] [Related]  

  • 34. The metabolism of copper and Wilson's disease.
    CUMINGS JN
    Proc Nutr Soc; 1962; 21():29-34. PubMed ID: 13882607
    [No Abstract]   [Full Text] [Related]  

  • 35. Hypercalciuria in hepatolenticular degeneration (Wilson's disease).
    Randall RV; Goldstein NP; Gross JB; Rosevear JW
    Am J Med Sci; 1966 Dec; 252(6):715-20. PubMed ID: 5954673
    [No Abstract]   [Full Text] [Related]  

  • 36. Aspects of copper metabolism in Wilson's disease.
    STOKES JB; BECK AB; TOPLISS JG; SAINT EG
    Australas Ann Med; 1955 Feb; 4(1):36-43. PubMed ID: 14363037
    [No Abstract]   [Full Text] [Related]  

  • 37. The amino acid content of the blood and urine in Wilson's disease.
    STEIN WH; BEARN AG; MOORE S
    J Clin Invest; 1954 Mar; 33(3):410-9. PubMed ID: 13143089
    [No Abstract]   [Full Text] [Related]  

  • 38. Abnormalities of copper metabolism in Wilson's disease; a preliminary report.
    CH'EN PE
    Chin Med J; 1957 Nov; 75(11):917-24. PubMed ID: 13500467
    [No Abstract]   [Full Text] [Related]  

  • 39. Metabolism of copper in Wilson's disease and in normal subjects; studies with Cu-64.
    EARL CJ; MOULTON MJ; SELVERSTONE B
    Am J Med; 1954 Aug; 17(2):205-13. PubMed ID: 13180528
    [No Abstract]   [Full Text] [Related]  

  • 40. [Copper and the wilsonian liver].
    STERNLIEB I
    Rev Med Chir Mal Foie; 1961 Sep; 36():147-58. PubMed ID: 13917020
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.